It is a chemicals private limited company based in Chandigarh, Chandigarh, India, established in 2015.
2015 | Chandigarh, Chandigarh, India | Struck OffNuumara Pharma (India) Private Limited, a struck off private limited company, was established on 11 March 2015 in Chandigarh, Chandigarh, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24232CH2015PTC035449. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Pavneet Kaur (Additional Director), Jas Karan Dhaliwal (Director). Past directors included John Danylowich, Barry Dean Walter Stecyk, Gagandeep Singh Dhaliwal. Its latest AGM occurred on 14 August 2016, with the balance sheet filed on 31 March 2016. It is based at Sco: - 117-118, Sector- 17-B,, Chandigarh, Chandigarh, 160017.
U24232CH2015PTC035449
035449
11 March 2015
₹0.10 M
₹0.10 M
Roc Chandigarh
Unlisted
Struck Off
Explore comprehensive insights into Nuumara Pharma (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pavneet Kaur | Additional Director | 31 May 2018 | Current |
| Jas Karan Dhaliwal | Director | 11 Mar 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 May 2018 | Past |
| Pramod Abcsdd | Director | 31 May 2018 | Past |
| Pramod Abcsdd | Director | 31 May 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nuumara Pharma (India) Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Nuumara Pharma (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Nuumara Pharma (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Nuumara Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nuumara Pharma (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Pavneet Kaur was appointed as a Additional Director was appointed as a Additional Director on 31 May 2018 & has been associated with this company since 7 years 6 months . was recorded as a recent event.
Progress on Nuumara Pharma (India) Private Limited last Annual general meeting of members was held on 14 Aug 2016 as per latest MCA records. was documented.
Nuumara Pharma (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Chandigarh. was recorded as a recent event.
The activity Jas Karan Dhaliwal was appointed as a Director was appointed as a Director on 11 Mar 2015 & has been associated with this company since 10 years 8 months . was completed.
The activity Nuumara Pharma (India) Private Limited was registered on 11 Mar 2015 with Roc Chandigarh & aged 10 years 8 months as per MCA records. was completed.
The CIN of Nuumara Pharma (India) Private Limited is U24232CH2015PTC035449.
Nuumara Pharma (India) Private Limited is headquartered at Sco: - 117-118, Sector- 17-B,, Chandigarh, Chandigarh, 160017.
Nuumara Pharma (India) Private Limited was incorporated on 11 March 2015.
The current directors of Nuumara Pharma (India) Private Limited are
The primary industry of Nuumara Pharma (India) Private Limited is Chemicals.
Nuumara Pharma (India) Private Limited is unlisted.
The authorized capital of Nuumara Pharma (India) Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX